TB-500

TB-500 is a synthetic fragment of thymosin beta-4 that promotes cell migration, angiogenesis, and tissue repair, run in the community mostly for acute injury and muscle healing. People typically dose around 500 mcg daily, spanning 200 mcg to 10 mg, while clinician protocols land higher at 2 to 2.5 mg daily subcutaneously over 4 to 12 weeks. Injection-site reactions surface occasionally in user reports, but nothing else has been a consistent theme. The honest caveat: there's no FDA-approved indication, all use is off-label, and roughly a third of participants withdrew across the registered trial program.

Half-life~3 days

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyClinicalResearchSideEffectsAnecdotalEfficacyAnecdotalSideEffectsPrice3.51.33.63.22.85.0

Research Evidence

Evidence shape

TB-500 currently holds a moderate evidence tier, though it lacks published human clinical trials to support its use. While ten registered trials exist across eleven distinct indications—including dry eye syndrome and various ulcer treatments—the research remains exploratory and limited to single-trial investigations. The quality of this data is constrained by a 40% withdrawal rate across the four blinded trials that have posted results, and the majority of the clinical landscape consists of long-tail, isolated studies that have not progressed to large-scale validation.

Depthhow much
10 registered trials
4 completed · 4 with posted results · 2 recruiting / active · combined n=225
Breadthhow many areas
11 indications mapped
6 thin / exploratory · 1 animal-only · 10 single-trial long-tail
Qualityhow rigorous
Highest tier: Phase 2
4 blinded with results · 3 distinct sponsors · 40% withdrawal rate · AE rows aggregated from 3 trials · 1 linked publication on registered trials
Breadth and depth33 rows captured
Human
direct clinical signal
10
Animal
translational support
12
In vitro
mechanistic support
11
HighMediumLow

Anecdotal efficacy

TB-500 side effects

Clinical research side effects

Anecdotal side effects

Price

Full buying guide →
1
Bio Supply Uk
GB
5000 mg
$52.35
$0.013/mg
2
Nurev Peptides
--
10 mg
$13.99
$1.4/mg
3
BOC Peptide
--
100 mg×10
$158.00
$1.58/mg
4
Mrbeetoe
--
50 mg
$90.00
$1.8/mg
5
Nextechlaboratories
US
10 mg
$20.00
$2/mg
6
Alphatide Labs
--
10 mg
$21.00
$2.1/mg

price offers can be sorted by column

1-6 of 317

TB-500 dosing & protocol

How TB-500 is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols · n = 4
Typical dose
—
0
2 mg
4 mg
6 mg
8 mg
10 mg
no dose captured for this tier yet
Frequency
single dose
Route
IV

No reliable dose information is available for the research‑trial tier of TB‑500; dosing was not reliably extracted across the four completed trials.

4 sources
Clinician practice
Doctor & published-protocol guidance · n = 3
Typical dose
2.5 mg2 mg – 2.5 mg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
distribution of 7 reported doses · darker = more
By reported cadence· tap a row to filter the chart
Frequency
daily
Route
subQ

Clinician sources most often report 2–2.5 mg of TB‑500 given subcutaneously daily, while one source lists a weekly 2.5 mg dose; no cycling protocol is mentioned.

3 sources
Anecdotal
Community-reported real-world use · n = 17
Typical dose
5 mg330 µg – 10 mg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
distribution of 20 reported doses · darker = more
By reported cadence· tap a row to filter the chart
Frequency
mostly daily
Route
subQ

Most community reports list TB‑500 without a specified schedule, usually around 5 mg, while about a quarter dose it daily at roughly 2 mg and a small fraction use it weekly at 5 mg.

17 sources

Related peptides

BPC-157Pentosan PolysulfateARA-290KPVKLOWWolverineB7-33